Skip to main contentSkip to footer
T

Trialytics

Find trialsHow it worksAboutFAQBlog
Home/Conditions/Polycythemia Vera/Massachusetts

Polycythemia Vera clinical trials in Massachusetts

3 active Polycythemia Vera trials with a site in Massachusetts. Describe your situation to see which ones you may be eligible for.

  • Ruxolitinib in Thrombocythemia and Polycythemia VeraRECRUITINGPhase 2NCT04644211
  • Study of INCA036978 in Participants With Myeloproliferative NeoplasmsRECRUITINGPhase 1NCT07441694
  • WELL-MPN: A Digital Lifestyle App for Patients With MPNsNOT_YET_RECRUITINGNCT07349134

Guides for people searching for a trial

  • How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
  • Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
  • How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
  • What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
  • 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
  • You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.

← All Polycythemia Vera trials

T

Trialytics

Clinical trials explained in plain language.

Product

  • How it Works
  • Search Trials
  • Browse by Condition
  • Browse by Biomarker

Company

  • About
  • Blog
  • Contact

Legal

  • Privacy Policy
  • Terms of Use
  • HIPAA Authorization
  • Request HIPAA Compliance Statement

© 2026 Trialytics. All rights reserved.